Drugs / GSK2590066A
last change Aug 2012 re-read 2 minutes ago

GSK2590066A

Developed for
influenza
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01236040 Nov 2010 → Sep 2011 influenza GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK2590066A ClinicalTrials.gov intervention name — accepted as the source's own label NCT01236040